Investing Experience -
Risk Profile -
Followers
0
Following
0
Blog Posts
0
Threads
1,457
Blogs
Threads
Portfolio
Follower
Following
Summary
Total comments
1,457
Past 30 days
0
Past 7 days
0
Today
0
User Comments
Stock
2021-10-04 11:03 | Report Abuse
Apply so many lots, not even 1 get so now the time to buy. Better still if drop to ipo price, can buy more
Stock
2021-10-04 10:28 | Report Abuse
Why worry, when u only acquire price at a small premium of about 5¢ over the ipo price.
Stock
2021-10-04 09:46 | Report Abuse
By right, if ancom at 2.40+, nylex should be at least 1.30
Stock
2021-10-04 09:29 | Report Abuse
Could today be the start of trend reversal for glove counters. Long pressed down n time for uptrend
Stock
2021-10-04 09:24 | Report Abuse
Already price so low. Ipo oversubscribed 131 times, just imagine, I applied for 200 lots, not even 1 get
Stock
2021-10-04 09:22 | Report Abuse
Not so sure it will drop to below ipo unless market crash.
Stock
Stock
2021-10-03 21:46 | Report Abuse
China gloves may be cheap but normally sold to developing n third world countries like Africa, Asia n South America. Developed countries prefer quality gloves from malaysia
Stock
2021-10-03 21:30 | Report Abuse
@burstard, well said. I agreed with u. Don't condemn others
Stock
Stock
Stock
Stock
Stock
2021-10-03 11:58 | Report Abuse
Finally a doctor in Singapore talks about the failure if the vaccine most Singaporeans have been administered to.
The message originated from Dr Gabriel Oon Chong Jin, a retired oncologist who is a pioneer in liver cancer research here.
Dr Oon, 82, played a key role in Singapore’s hepatitis B vaccination programme that began in the late 1970s. Hepatitis B is a liver infection caused by a virus.
When contacted by TODAY on Friday, Dr Oon, who last practised at Mount Elizabeth Medical Centre, confirmed that the content of the message was from him.
In the message, he wrote that mutations in the spike protein of the coronavirus causing Covid-19 has altered its antigenicity — or its ability to bind to cell walls.
The spike protein is the part of the virus that it uses to penetrate human cells so that it can bind with the cells more effectively and cause infection.
When the antigenicity changes, vaccines that use the new mRNA technology such as Pfizer-BioNTech cannot recognise the mutant variant such as the B1617 one.
Only a vaccine such as Sinovac that has an inactivated virus “with all its seven antigens” can still produce an immune response even when one antigen of the active invading virus is affected by mutation, Dr Oon wrote.
He added that the B1617 variant had successfully infected vaccinated frontliners and airport staff members, as well as school children in Singapore.
“Pfizer is useless now and obsolete in the presence of mutations on (the) spike gene,” the message read.
He also said in the message that “China vaccines” can overcome the B1617 variant and that he had written in to the authorities to consider using Sinovac.
The Sinovac vaccine may be suitable for children, and even babies, but at a lowered dosage, he added.
When asked by TODAY to comment more about his concerns, Dr Oon stressed again that mRNA vaccines are “useless” against the B1617 mutant and that the variant should be seen as a “new infection”.
“I would say it is a time of emergency, a time to change and use another vaccine such as Sinovac, which we already have in stock,” he said, referring to the shipment of the vaccine Singapore received in February and pending approval for use here.
Dr Oon continued: “If we keep vaccinating people with mRNA vaccines like Pfizer, we are endangering the lives of so many people around us who will still get infected, not to mention the person who is vaccinated."
It is a doctor's duty to call immediately for a change of treatment if it is not working for a patient who has a life-threatening condition, he said by way of example.
In offering his views on Covid-19, he said: “I did it for the love of my country and humanity.”
Dr Oon’s circulated message on WhatsApp mentioned that he had reached out to various Cabinet ministers, including Health Minister Ong Ye Kung, on the mRNA vaccines and Sinovac.
Dr Oon confirmed that he had done this, at around the time news broke of the B1617 variant.
He declined to give more details on the recommendations he proposed to the Government as mentioned in the message.
TODAY understands that MOH is aware of Dr Oon’s circulated message since last month and had addressed some of his concerns in the same statement last month issued regarding the open letter by the doctors to parents.
That statement did not address Dr Oon’s concerns on how effective mRNA vaccines are on mutated variants.
Read more at https://www.todayonline.com/singapore/covid-19-private-clinics-be-chosen-provide-sinovac-vaccine-fees-selected-vaccine-takers-be-reimbursed
*Hong Kong*
Population: 7.5 million.
No of Covid cases: 7
(24 Sep 2021)
Average over last 7 days:
3 cases
Vaccination: 57%
*Singapore*
Population: 5.7 million.
No of Cases: 1650
(24 Sep 2021)
Average over last 7 days: 1247 cases.
Vaccination: 82%
Source: CSSE John Hopkins University
_Why the huge difference? Do the vaccines make the difference?_
*Hongkong uses mostly Sinovac and Sinopharm. Singapore uses mostly Pfizer & Moderna.*
Stock
2021-10-03 11:57 | Report Abuse
Finally a doctor in Singapore talks about the failure if the vaccine most Singaporeans have been administered to.
The message originated from Dr Gabriel Oon Chong Jin, a retired oncologist who is a pioneer in liver cancer research here.
Dr Oon, 82, played a key role in Singapore’s hepatitis B vaccination programme that began in the late 1970s. Hepatitis B is a liver infection caused by a virus.
When contacted by TODAY on Friday, Dr Oon, who last practised at Mount Elizabeth Medical Centre, confirmed that the content of the message was from him.
In the message, he wrote that mutations in the spike protein of the coronavirus causing Covid-19 has altered its antigenicity — or its ability to bind to cell walls.
The spike protein is the part of the virus that it uses to penetrate human cells so that it can bind with the cells more effectively and cause infection.
When the antigenicity changes, vaccines that use the new mRNA technology such as Pfizer-BioNTech cannot recognise the mutant variant such as the B1617 one.
Only a vaccine such as Sinovac that has an inactivated virus “with all its seven antigens” can still produce an immune response even when one antigen of the active invading virus is affected by mutation, Dr Oon wrote.
He added that the B1617 variant had successfully infected vaccinated frontliners and airport staff members, as well as school children in Singapore.
“Pfizer is useless now and obsolete in the presence of mutations on (the) spike gene,” the message read.
He also said in the message that “China vaccines” can overcome the B1617 variant and that he had written in to the authorities to consider using Sinovac.
The Sinovac vaccine may be suitable for children, and even babies, but at a lowered dosage, he added.
When asked by TODAY to comment more about his concerns, Dr Oon stressed again that mRNA vaccines are “useless” against the B1617 mutant and that the variant should be seen as a “new infection”.
“I would say it is a time of emergency, a time to change and use another vaccine such as Sinovac, which we already have in stock,” he said, referring to the shipment of the vaccine Singapore received in February and pending approval for use here.
Dr Oon continued: “If we keep vaccinating people with mRNA vaccines like Pfizer, we are endangering the lives of so many people around us who will still get infected, not to mention the person who is vaccinated."
It is a doctor's duty to call immediately for a change of treatment if it is not working for a patient who has a life-threatening condition, he said by way of example.
In offering his views on Covid-19, he said: “I did it for the love of my country and humanity.”
Dr Oon’s circulated message on WhatsApp mentioned that he had reached out to various Cabinet ministers, including Health Minister Ong Ye Kung, on the mRNA vaccines and Sinovac.
Dr Oon confirmed that he had done this, at around the time news broke of the B1617 variant.
He declined to give more details on the recommendations he proposed to the Government as mentioned in the message.
TODAY understands that MOH is aware of Dr Oon’s circulated message since last month and had addressed some of his concerns in the same statement last month issued regarding the open letter by the doctors to parents.
That statement did not address Dr Oon’s concerns on how effective mRNA vaccines are on mutated variants.
Read more at https://www.todayonline.com/singapore/covid-19-private-clinics-be-chosen-provide-sinovac-vaccine-fees-selected-vaccine-takers-be-reimbursed
*Hong Kong*
Population: 7.5 million.
No of Covid cases: 7
(24 Sep 2021)
Average over last 7 days:
3 cases
Vaccination: 57%
*Singapore*
Population: 5.7 million.
No of Cases: 1650
(24 Sep 2021)
Average over last 7 days: 1247 cases.
Vaccination: 82%
Source: CSSE John Hopkins University
_Why the huge difference? Do the vaccines make the difference?_
*Hongkong uses mostly Sinovac and Sinopharm. Singapore uses mostly Pfizer & Moderna.*
Stock
2021-10-03 09:45 | Report Abuse
It may many years before the drug by mersk will get official approval for use by the general public. Meanwhile vaccine is still the way to go forward although vaccines are not 100% effective n booster shots are needed in countries like israel
Stock
2021-10-02 21:58 | Report Abuse
FDA have yet to give any approval to this drug by mersk. Without this all important approval, the drug cannot be made available to the American general public not to mention sold in Malaysia
Stock
2021-10-02 21:53 | Report Abuse
Gloves are needed not only by healthcare sector, many like f & b, manufacturing, airline, service, school labs, etc also use gloves. So there's a wide range of sectors, gloves can cater to, not just limited to healthcare use.
Stock
2021-10-02 21:35 | Report Abuse
The drug by mersk has still yet to get FDA approval so not allowed to be sold to the American general public, not to mention overseas
Stock
2021-10-02 21:28 | Report Abuse
@hostan, have u included the broker's fees n stamp duties when arrived at this 8% per annum
Stock
2021-10-02 20:08 | Report Abuse
FDA have yet to give approval to this drug by Merck. It may take years to get approval as with any other drug under clinical trial test.
Stock
2021-10-02 20:03 | Report Abuse
FDA have yet to give approval to this drug. As with any other drug under clinical trial tests, it may take years before it will get approval for public usage.
Stock
Stock
Stock
2021-10-02 17:47 | Report Abuse
Even lwc n family also started acquiring tg shares so who are we to worry about?
Stock
2021-10-02 17:40 | Report Abuse
FDA is yet to approve this drug.
Stock
2021-10-02 17:37 | Report Abuse
@singor, at this price, many negative news had already been factored into. Nothing to worry anymore. There's only limited downside so potential for price upside is more.
Stock
2021-10-02 16:25 | Report Abuse
@dividenplayer, why not average down if one have a lot of funds to spare. But I am sure many retailers got stuck in the downturn n in the process, not much are left. I am sure by holding this stock long term, one should be able to recover back money lost but not so sure if one enter at a very high price ex bonus $9.
Stock
Stock
Stock
Stock
Stock
Stock
Stock
2021-10-02 12:22 | Report Abuse
@canbuyla, probably u are right. How many times can a share bounce back
Stock
2021-10-02 11:35 | Report Abuse
The reality is currently there's no solution yet to eradicate this covid. Vaccine can do the job to a certain extent but it had shown that it's not enough to control the spread as evidenced in Israel, Singapore n many countries
Stock
2021-10-02 10:24 | Report Abuse
Till now there's no effective treatment for covid yet. Nothing is certain. We may just have to live with it
Stock
2021-10-02 10:21 | Report Abuse
There will always be new variants evolving so this covid cannot be eradicated. As long as there is a human host around, virus will have chance to evolve into new variants. Hans just have to live with it
Stock
2021-10-01 23:16 | Report Abuse
Think of picking up the shares after seeing dropped so low but still scary. This a goreng counter, I think
Stock
Stock
2021-10-01 23:10 | Report Abuse
Institutional funds started buying into ancom. Confirmed news
Stock
Stock
Stock
2021-10-01 16:53 | Report Abuse
Why ancom so high price but nylex not even half of ancom
Stock
2021-10-01 16:37 | Report Abuse
This stock is for the bravest n fearless, salute those who go in at this price
Stock
Stock
2021-10-01 16:00 | Report Abuse
Euro is on a freefall. Don't know how deep the pit is. Bottomless pit, it seems
Stock
2021-10-01 15:55 | Report Abuse
Just when u think the price is so low, it will go lower still.
Stock
Stock: [CEKD]: CEKD BERHAD
2021-10-04 13:31 | Report Abuse
Their customer are highly diversified from various industries n fields so they don't just depends on one which will mitigate the risk